Boothbay Fund Management »

Passage Bio shares owned by Boothbay Fund Management

Quarter-by-quarter ownership of Passage Bio (PASG) shares owned by Boothbay Fund Management from 13F filings

Historical chart of Boothbay Fund Management investment in Passage Bio

Tip: Access up to 7 years of quarterly data

All positions including Passage Bio held by Boothbay Fund Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Passage Bio by Boothbay Fund Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $148k 19k 7.85

More positions owned by Boothbay Fund Management

At&t Call Option (T)
State Str Spdr S&p 500 Etf T Tr Unit Call Option (SPY)
Revolution Medicines Call Option (RVMD)
Ishares Tr Russell 2000 Etf Call Option (IWM)
NVIDIA Corporation Put Option (NVDA)
Tesla Motors Call Option (TSLA)
Abivax Sa Sponsored Ads (ABVX)
Ge Aerospace Com New Call Option (GE)
Invesco Exch Traded Fd Tr Ii Kbw Bk Etf Call Option (KBWB)
Microsoft Corporation Put Option (MSFT)
Amazon Call Option (AMZN)
Cornerstone Strategic Value (CLM)
Mineralys Therapeutics Put Option (MLYS)
United Therapeutics Corporation Call Option (UTHR)
Constellation Brands Cl A Call Option (STZ)

View all positions for Boothbay Fund Management

Top funds holding Passage Bio

Lynx1 Capital Management
Vestal Point Capital
Vanguard Group
Eversept Partners
Vanguard Capital Management
Renaissance Technologies
Yiheng Capital
Erste Asset Management GmbH
Ikarian Capital
Geode Capital Management
BlackRock
UBS Group
Acadian Asset Management
Boothbay Fund Management
Vanguard Fiduciary Trust

View all funds holding Passage Bio